l
ivaska
jukani
utufi
j
nojoaa
utufi
j
lempainen
riikkaosterback
utufi
r
osterback
mwari
utufi
wari
tyvuori
utufi
vuorinen
jukhyt
utufi
j
kaisurantakokkojalava
tyksfi
k
rantakokkojalava
vilpel
utufi
v
peltola
journal
infect
frequent
detect
virus
blood
mxa
level
higher
children
viral
mgl
median
iqr
concomit
gasvir
mgl
sole
ga
mgl
infect
conclus
detect
respiratori
virus
simultan
elev
blood
mxa
level
support
caus
role
virus
major
children
pharyng
keyword
viral
aetiolog
pharyng
myxoviru
resist
protein
mxa
group
streptococcu
ga
summari
object
besid
group
streptococcu
ga
microbi
caus
pharyng
children
well
known
aim
document
viral
bacteri
aetiolog
pharyng
assess
pathogen
role
virus
determin
myxoviru
resist
protein
mxa
blood
marker
interferon
respons
method
prospect
observ
studi
throat
swab
blood
sampl
collect
children
age
year
present
emerg
depart
febril
pharyng
microbi
caus
sought
bacteri
cultur
polymeras
chain
reaction
serolog
blood
mxa
level
determin
result
potenti
pathogen
detect
patient
ga
alon
ga
virus
group
c
g
streptococci
alon
togeth
virus
virus
alon
case
enterovirus
rhinovirus
adenovirus
introduct
acut
pharyng
account
substanti
portion
visit
physician
outpati
set
group
streptococcu
ga
common
bacteri
caus
pharyng
justifi
antimicrobi
treatment
accord
current
guidelin
howev
overus
antibiot
pharyng
occur
children
adult
nonga
pharyng
suggest
mainli
viral
infect
comprehens
studi
evalu
microbiolog
aetiolog
diseas
paediatr
popul
lack
studi
address
viral
aetiolog
pharyng
children
adolesc
molecular
diagnost
method
preval
asymptomat
streptococc
carriag
oropharynx
complic
causal
interpret
ga
find
children
symptomat
pharyng
addit
signific
respiratori
viru
detect
polymeras
chain
reaction
pcr
question
frequent
viru
find
asymptomat
subject
among
patient
posit
viral
pcr
result
low
cycl
threshold
ct
serolog
respons
indic
true
infect
altern
approach
distinguish
viral
bacteri
infect
differ
biomark
blood
concentr
host
gene
express
pattern
aim
studi
document
microbi
caus
acut
pharyng
children
adolesc
outpati
set
evalu
caus
role
virus
determin
myxoviru
resist
protein
mxa
biomark
level
prospect
observ
studi
conduct
depart
emerg
servic
turku
univers
hospit
turku
finland
novemb
januari
depart
emerg
servic
ed
serv
walkin
clinic
approxim
yearli
visit
patient
age
children
adolesc
age
year
acut
febril
pharyng
elig
studi
exclus
criteria
studi
studi
protocol
inclus
criteria
introduc
ed
physician
diagnos
acut
pharyng
defin
exud
intens
red
tonsilsoropharynx
fever
bodi
temperatur
c
measur
ed
report
parent
current
ill
episod
patient
treat
accord
judgement
attend
ed
physician
local
guidelin
recommend
oral
phenoxymethylpenicillin
first
line
cephalexin
second
line
antimicrobi
therapi
microbiolog
proven
ga
pharyng
enrol
patient
symptom
durat
clinic
examin
find
preced
ill
vaccin
underli
condit
record
oropharyng
swab
sampl
blood
sampl
obtain
symptom
diari
card
given
parent
particip
children
famili
contact
telephon
enrol
visit
record
durat
patient
symptom
followup
call
continu
everi
second
day
fever
sore
throat
resolv
patient
invit
followup
visit
approxim
week
enrol
followup
visit
possibl
symptom
clinic
find
record
oropharyng
swab
sampl
blood
sampl
pair
serolog
obtain
ethic
committe
hospit
district
southwest
finland
approv
studi
protocol
legal
guardian
particip
children
adolesc
adolesc
patient
gave
written
inform
consent
enrol
oropharyng
sampl
collect
standard
order
rub
swab
tonsil
throat
swab
handl
follow
sampl
bacteri
cultur
collect
flock
swab
put
immedi
collect
tube
liquid
transport
media
eswab
copan
brescia
itali
transfer
depart
clinic
microbiolog
turku
univers
hospit
sampl
viru
pcr
collect
flock
swab
copan
brescia
itali
transfer
dri
clean
tube
depart
clinic
virolog
turku
univers
hospit
followup
visit
studi
physician
collect
flock
swab
sampl
viru
pcr
fifti
microlitr
vortex
eswab
inocul
streptococcalselect
blood
agar
standard
blood
mcleod
fastidi
anaerob
agar
well
streptococcalselect
broth
follow
subcultur
streptococcalselect
blood
agar
beta
haemolyt
streptococci
coloni
interest
identifi
standard
method
includ
malditof
bruker
dalton
bremen
germani
antistreptolysin
aso
antibodi
level
determin
use
rapitex
asl
kit
siemen
healthcar
diagnost
product
gmbh
marburg
germani
accord
manufactur
instruct
pharyng
swab
suspend
phosphatebuff
salin
nucleic
acid
extract
use
nuclisen
easymag
biomerieux
boxtel
netherland
autom
extractor
anyplex
ii
multiplex
pcr
system
seegen
seoul
korea
use
detect
influenza
b
virus
respiratori
syncyti
viru
rsv
group
b
adenoviru
metapneumoviru
coronavirus
parainfluenza
viru
type
rhinovirus
enterovirus
bocaviru
addit
laboratorydevelop
pcr
assay
use
detect
rhinovirus
enterovirus
amplif
perform
use
rotorgen
qiagen
q
qiagen
hilden
germani
instrument
enterovirusand
adenovirusposit
specimen
subject
genotyp
pcr
amplif
partial
gene
region
enteroviru
protein
region
adenoviru
hexon
protein
amplicon
purifi
exosap
protocol
sequenc
gatc
biotech
constanc
germani
obtain
sequenc
analys
ncbi
basic
local
align
tool
pair
serum
sampl
store
c
analys
commerci
test
kit
use
detect
igg
igm
antibodi
mycoplasma
pneumonia
labsystem
diagnost
vantaa
finland
epsteinebarr
viru
ebv
vida
biomerieux
marci
l
etoil
franc
accord
manufactur
instruct
igg
antibodi
adenoviru
enterovirus
influenza
b
virus
parainfluenza
viru
type
rsv
analys
inhous
enzym
immunoassay
routin
use
viru
diagnost
laboratori
mcaptur
enzym
immunoassay
use
measur
enterovirusspecif
igm
antibodi
mixtur
coxsackieviru
coxsackieviru
echoviru
antigen
use
igg
igm
test
enterovirus
biomark
whole
blood
plasma
serum
sampl
biomark
level
determin
collect
enrol
visit
antecubit
venepunctur
white
blood
cell
count
plasma
level
creactiv
protein
crp
procalcitonin
pct
determin
hospit
central
laboratori
whole
blood
sampl
mxa
measur
transport
laboratori
sampl
dilut
hypoton
buffer
store
c
eia
analysi
perform
describ
earlier
serum
sampl
tumour
necrosi
factor
tnf
relat
apoptosisinduc
ligand
trail
level
determin
store
c
analysi
elisa
human
trail
quantikin
r
system
inc
minneapoli
usa
accord
manufactur
protocol
optic
densiti
determin
use
micropl
reader
set
nm
wavelength
correct
nm
statist
comparison
patient
enrol
studi
classifi
two
etiolog
group
patient
ga
diagnosi
base
bacteri
cultur
gasvir
pharyng
classifi
ga
patient
aetiolog
undetermin
aetiolog
classifi
nonga
group
compar
c
mannewhitney
u
test
area
receiv
oper
characterist
roc
curv
determin
biomark
furthermor
patient
classifi
accord
microbi
find
six
separ
group
descript
analysi
analys
perform
use
ibm
spss
statist
version
ibm
corp
armonk
ny
usa
studi
popul
compris
children
adolesc
febril
pharyng
tabl
median
age
children
year
interquartil
rang
girl
none
admit
includ
cardiolog
n
z
neurolog
n
z
condit
ankylos
spondyl
n
z
vitiligo
n
z
b
number
applic
patient
n
z
hospit
five
children
receiv
antibiot
within
day
enrol
potenti
caus
agent
detect
patient
ga
alon
ga
togeth
viru
group
c
g
bhaemolyt
streptococci
gc
gg
alon
two
gc
gg
togeth
viru
three
one
virus
alon
case
fig
one
ga
case
diagnos
enrich
cultur
remain
detect
standard
cultur
streptococcalselect
blood
agar
plate
bacteria
found
throat
cultur
consid
nonpathogen
supplement
tabl
signific
differ
mean
initi
serum
aso
level
ga
nonga
patient
five
patient
show
aso
increas
pair
serum
sampl
three
ga
posit
one
gc
posit
one
neg
streptococci
throat
cultur
overal
pair
serum
sampl
avail
patient
ga
frequent
detect
virus
enterovirus
children
rhinovirus
adenovirus
common
type
enterovirus
coxsackieviru
type
adenovirus
type
seven
patient
two
patient
ebv
igm
antibodi
detect
five
patient
howev
durat
symptom
presenc
igg
antibodi
result
pair
serum
sampl
consid
acut
infect
caus
ebv
confirm
two
patient
pneumonia
igm
antibodi
detect
togeth
igg
antibodi
serum
patient
seven
year
old
pair
serum
sampl
avail
four
patient
none
show
increas
pneumonia
igg
antibodi
level
bhaemolyt
streptococci
viru
detect
patient
figur
aetiolog
febril
pharyng
differ
age
group
n
z
vertic
axi
display
percentag
microorgan
detect
group
streptococcu
ga
light
blue
ga
viru
orang
group
c
streptococcu
gc
group
g
streptococcu
gg
grey
gcsgg
viru
yellow
viru
dark
blue
microbiolog
aetiolog
unknown
green
horizont
axi
x
repres
differ
age
group
includ
studi
year
old
serolog
result
abl
plausibl
estim
import
viru
patient
multipl
viru
find
supplement
tabl
result
suggest
despit
frequent
codetect
virus
enterovirus
adenoviru
often
also
probabl
pharyng
pathogen
virus
caus
major
case
age
group
viral
aetiolog
particularli
common
age
group
one
four
year
fig
occurr
select
symptom
clinic
find
patient
ga
nonga
pharyng
present
tabl
clinic
score
system
use
clinic
manag
patient
mcisaac
score
determin
retrospect
elig
patient
n
z
none
symptom
clinic
find
mcisaac
score
specif
ga
nonga
aetiolog
febril
pharyng
white
blood
cell
count
crp
pct
mxa
trail
level
measur
blood
plasma
serum
pharyng
patient
mxacrp
ratio
calcul
level
biomark
except
pct
significantli
differ
ga
nonga
patient
tabl
howev
none
biomark
accur
discrimin
ga
nonga
aetiolog
see
supplement
fig
base
previou
studi
use
mgl
cutoff
level
increas
blood
mxa
concentr
blood
mxa
level
elev
patient
viru
find
remain
low
patient
streptococc
pharyng
without
viru
detect
blood
mxa
level
also
elev
patient
without
confirm
microbiolog
diagnosi
fig
virus
bacteria
identifi
five
patient
recent
antibiot
exposur
patient
also
markedli
elev
blood
mxa
level
indic
acut
viru
infect
total
patient
return
schedul
followup
visit
day
median
day
interquartil
rang
followup
visit
throat
swab
taken
blood
sampl
children
fever
throat
sore
initi
pharyng
episod
resolv
patient
two
patient
present
followup
visit
relaps
ga
pharyng
anoth
febril
none
patient
febril
followup
visit
report
milder
respiratori
symptom
overal
virus
detect
patient
viru
detect
common
symptomat
asymptomat
patient
blood
mxa
level
lower
viru
posit
patient
followup
visit
mgl
median
iqr
febril
pharyng
episod
mgl
studi
virus
domin
role
aetiolog
febril
pharyng
possibl
caus
agent
could
detect
viru
patient
wherea
earlier
studi
era
pcr
virus
detect
children
adolesc
pharyng
tonsil
furthermor
elev
blood
mxa
level
marker
type
type
iii
interferon
product
demonstr
activ
innat
immun
respons
acut
viru
infect
major
patient
detect
viru
detect
group
bhaemolyt
streptococci
less
frequent
earlier
report
partli
explain
fact
half
children
studi
tabl
comparison
clinic
paramet
biomark
ga
nonga
pharyng
nonga
n
z
p
younger
five
year
old
group
c
g
bhaemolyt
streptococci
detect
infrequ
often
togeth
virus
suggest
pneumonia
major
pharyng
pathogen
children
studi
detect
rate
pneumonia
igm
antibodi
howev
consid
durat
patient
symptom
presenc
potenti
pathogen
presenc
igg
antibodi
miss
titr
chang
pair
sera
clinic
signific
pneumonia
igm
antibodi
find
remain
unclear
respiratori
virus
detect
pcr
mani
asymptomat
individu
well
therefor
role
etiolog
agent
argu
other
shown
earlier
mxa
respons
strongli
associ
symptomat
viral
infect
inde
present
studi
patient
viru
find
elev
level
mxa
protein
blood
contrast
followup
visit
patient
asymptomat
minor
nonfebril
respiratori
symptom
blood
mxa
level
remain
low
find
suggest
enrol
true
symptomat
viru
infect
rather
coincident
viru
detect
still
one
patient
febril
pharyng
posit
group
c
g
bhaemolyt
streptococci
without
viru
detect
demonstr
mxa
respons
interestingli
nine
ten
patient
without
confirm
microbiolog
diagnosi
increas
mxa
level
find
suggest
major
patient
might
infect
caus
undetect
viru
enterovirus
often
detect
pathogen
studi
observ
probabl
result
two
fact
first
use
pcr
assay
instead
viral
cultur
diagnost
increas
detect
rate
enterovirus
second
epidemiolog
factor
influenc
result
autumn
substanti
report
enteroviru
infect
finland
two
previou
year
especi
children
younger
year
old
virus
detect
togeth
bhaemolyt
streptococci
patient
rhinovirus
adenovirus
frequent
viru
find
patient
detect
rhinoviru
asymptomat
subject
uncommon
adenoviru
persist
tonsillar
tissu
pathogen
role
virus
alway
clear
howev
patient
mxa
respons
suggest
patient
either
viralbacteri
coinfect
viru
infect
incident
ga
carriag
biomark
bacteri
infect
limit
clinic
util
distinguish
ga
nonga
pharyng
found
signific
differ
blood
level
wbc
crp
mxa
trail
mxacrp
ratio
patient
ga
nonga
ill
analyt
perform
measur
auc
poor
mxa
could
discrimin
ga
nonga
aetiolog
pharyng
mainli
streptococc
viral
coinfect
induc
mxa
respons
compar
viru
infect
ga
detect
rel
easili
throat
swab
probabl
clinic
need
biomark
routin
diagnost
ga
pharyng
studi
biomark
primarili
assess
pathogen
role
detect
virus
bacteria
evalu
perform
differenti
diagnost
clinic
practic
howev
mxa
level
mxacrp
ratio
remain
low
patient
sole
streptococc
infect
increas
major
patient
viru
infect
therefor
could
help
repres
blood
myxoviru
resist
protein
mxa
level
differ
aetiolog
group
patient
febril
pharyng
n
z
vertic
axi
display
mxa
protein
concentr
mgl
whole
blood
scale
axi
logarithm
horizont
axi
x
repres
differ
aetiolog
group
group
streptococcu
ga
ga
viru
group
c
streptococcu
gc
group
g
streptococcu
gg
gcsgg
viru
viru
unknown
tool
differenti
diagnosi
viral
bacteri
infect
clinic
set
studi
blood
level
trail
anoth
viru
specif
biomark
less
accur
differenti
viral
bacteri
aetiolog
studi
sever
limit
first
singlecentr
studi
therefor
result
might
fulli
generaliz
centr
moreov
patient
recruit
continu
month
epidemiolog
variat
might
influenc
etiolog
outcom
addit
sampl
size
rather
small
sever
differ
ed
physician
carri
preliminari
recruit
patient
could
influenc
diagnost
accuraci
pharyng
howev
set
pragmat
reflect
clinician
identifi
febril
pharyng
furthermor
could
possibl
increas
detect
rate
virus
collect
also
nasopharyng
swab
sampl
rational
sole
oropharyng
sampl
investig
pharyng
infect
nasopharyng
sampl
might
increas
detect
virus
question
role
caus
pharyng
symptom
virus
common
caus
febril
pharyng
children
adolesc
studi
reinforc
current
practic
spare
patient
nonga
ill
antibiot
treatment
biomark
measur
seem
clinic
irrelev
diagnost
pharyng
nevertheless
blood
mxa
potenti
biomark
acut
viru
infect
conflict
interest
